Advertisement
Research Article

Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study

  • Line D. Rasmussen mail,

    linedahlerup@hotmail.com

    Affiliation: Department of Infectious Diseases, Odense University Hospital, Odense, Denmark

    X
  • Elisabeth R. Mathiesen,

    Affiliation: Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

    X
  • Gitte Kronborg,

    Affiliation: Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark

    X
  • Court Pedersen,

    Affiliation: Department of Infectious Diseases, Odense University Hospital, Odense, Denmark

    X
  • Jan Gerstoft,

    Affiliation: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

    X
  • Niels Obel

    Affiliation: Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

    X
  • Published: September 12, 2012
  • DOI: 10.1371/journal.pone.0044575

About the Authors

Line D. Rasmussen, Court Pedersen
Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
Elisabeth R. Mathiesen
Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Gitte Kronborg
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark
Jan Gerstoft, Niels Obel
Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Corresponding Author

Email: linedahlerup@hotmail.com

Competing Interests

The authors read the journal's policy and declare the following potential conflicts of interest. N. Obel has received research funding from Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Abbott, Boehringer Ingelheim, Janssen-Cilag and Swedish Orphan Drugs. C. Pedersen has received research funding from Abbott, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. J. Gerstoft has received research funding from Abbott, Roche, Bristol-Myers Squibb, Mecrk Sharp & Dohme, Pharmasia, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. E.R. Mathiesen, G. Kronborg and L.D. Rasmussen report no conflicts of interest. The potential conflicts of interest described above do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the analytical strategy: LDR ERM NO. Collected and assembled the data/patients: CP GK JG NO. Conducted the literature review: LDR ERM. Analyzed and interpreted the data: LDR GK CP JG NO. Statistical expertise: LDR NO. Wrote the manuscript: Drafting of the article: LDR. Revised the article critically for important intellectual content: LDR ERM GK CP JG NO. Performed the final approval of the article: LDR ERM GK CP JG NO. Obtained the funding: NO CP GK JG. Performed the administrative, technical, or logistic support: LDR NO.